Peter MacCallum Cancer Centre,
Melbourne, Australia

Professor Shankar Siva and leads the stereotactic body radiotherapy (SABR) service at the Peter MacCallum Cancer Centre. He leads 5 international multicentre trials through the TransTasman Radiation Oncology Group (TROG) with a focus in SABR. He has over 250 publications, with his current research focused on high-tech radiotherapy delivery, in the context immunotherapy combinations, oligometastatic disease, kidney cancer and prostate cancer.